Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Consolidated Financial Performance & Key Metrics
SYK logo

Stryker's Net Sales Surge 10% Amid Inari Acquisition Boost

SYK10-QFiling Date: 10/31/2025
Stryker Corporation
Description

What this story covers

Stryker reported Q3 net sales of 6.1 billion dollars, up 10.3 percent, driven by 9.1 percent volume growth in MedSurg/Neurotechnology. Inari acquisition added vascular strength; spine divestiture streamlined ops. Cash flow hit 2.9 billion dollars, supporting 5 billion dollars investments. Adjusted earnings per share rose 11 percent, navigating tariffs and costs.

Story snapshot

CompanyStryker Corporation
TickerSYK
VariantStandard detailed
Duration9:46
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0000310764-25-000129

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in